Back to Search
Start Over
436P Phase Ib/II study of the polo-like kinase 1 (PLK1) inhibitor, onvansertib, in combination with FOLFIRI and bevacizumab for second line treatment of KRAS-mutated metastatic colorectal cancer
- Source :
- Annals of Oncology. 31:S427
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
Details
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........4e6e5d938514067ad9f97e8d2abe9ae2
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.08.547